| Primary |
| Schizophrenia |
24.8% |
| Bipolar Disorder |
17.4% |
| Depression |
13.8% |
| Psychotic Disorder |
8.8% |
| Schizophrenia, Paranoid Type |
4.8% |
| Anxiety |
4.2% |
| Schizoaffective Disorder |
3.9% |
| Bipolar I Disorder |
3.5% |
| Insomnia |
3.1% |
| Hypertension |
2.3% |
| Agitation |
2.2% |
| Mental Disorder |
2.0% |
| Major Depression |
1.7% |
| Mania |
1.2% |
| Product Used For Unknown Indication |
1.2% |
| Sleep Disorder |
1.2% |
| Affective Disorder |
1.1% |
| Dementia |
1.0% |
| Epilepsy |
0.9% |
| Abnormal Behaviour |
0.8% |
|
| Weight Increased |
27.5% |
| Pancreatitis |
11.5% |
| Diabetes Mellitus |
6.1% |
| Death |
6.0% |
| Overdose |
5.8% |
| Weight Decreased |
4.3% |
| Pulmonary Embolism |
3.8% |
| Vision Blurred |
3.6% |
| White Blood Cell Count Decreased |
3.3% |
| Metabolic Disorder |
3.3% |
| Off Label Use |
3.2% |
| Renal Failure |
2.9% |
| Obesity |
2.8% |
| Prescribed Overdose |
2.7% |
| Myocardial Infarction |
2.5% |
| Neutropenia |
2.4% |
| Drug Exposure During Pregnancy |
2.2% |
| Hospitalisation |
2.1% |
| Thrombocytopenia |
2.1% |
| Completed Suicide |
2.0% |
|
| Secondary |
| Schizophrenia |
17.1% |
| Bipolar Disorder |
13.4% |
| Depression |
13.3% |
| Product Used For Unknown Indication |
8.2% |
| Drug Use For Unknown Indication |
8.2% |
| Anxiety |
5.3% |
| Psychotic Disorder |
4.9% |
| Bipolar I Disorder |
4.6% |
| Schizophrenia, Paranoid Type |
4.1% |
| Schizoaffective Disorder |
3.6% |
| Insomnia |
2.9% |
| Sleep Disorder |
2.7% |
| Major Depression |
2.5% |
| Hypertension |
1.7% |
| Agitation |
1.6% |
| Mental Disorder |
1.5% |
| Affective Disorder |
1.3% |
| Pain |
1.2% |
| Mania |
1.1% |
| Epilepsy |
0.8% |
|
| Weight Increased |
30.6% |
| Type 2 Diabetes Mellitus |
12.4% |
| Diabetes Mellitus |
9.2% |
| Overdose |
6.9% |
| Pancreatitis |
4.6% |
| Tremor |
3.4% |
| Suicide Attempt |
3.1% |
| Polytraumatism |
3.0% |
| Weight Decreased |
2.9% |
| White Blood Cell Count Increased |
2.7% |
| Off Label Use |
2.6% |
| Vomiting |
2.5% |
| Somnolence |
2.3% |
| White Blood Cell Count Decreased |
2.2% |
| Pulmonary Embolism |
2.1% |
| Psychotic Disorder |
2.1% |
| Tardive Dyskinesia |
1.9% |
| Vision Blurred |
1.9% |
| Suicidal Ideation |
1.8% |
| Neutropenia |
1.7% |
|
| Concomitant |
| Depression |
18.0% |
| Bipolar Disorder |
14.0% |
| Schizophrenia |
11.3% |
| Product Used For Unknown Indication |
9.2% |
| Anxiety |
7.7% |
| Drug Use For Unknown Indication |
6.6% |
| Insomnia |
5.0% |
| Sleep Disorder |
4.8% |
| Pain |
3.0% |
| Hypertension |
2.9% |
| Psychotic Disorder |
2.8% |
| Schizoaffective Disorder |
2.0% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Schizophrenia, Paranoid Type |
1.7% |
| Prophylaxis |
1.6% |
| Mental Disorder |
1.6% |
| Bipolar I Disorder |
1.6% |
| Diabetes Mellitus |
1.5% |
| Affective Disorder |
1.3% |
| Smoking Cessation Therapy |
1.3% |
|
| Type 2 Diabetes Mellitus |
31.8% |
| Weight Increased |
12.9% |
| Pancreatitis |
8.2% |
| Diabetes Mellitus |
4.9% |
| Vomiting |
4.4% |
| Tardive Dyskinesia |
4.2% |
| Weight Decreased |
4.1% |
| Tremor |
3.5% |
| Suicidal Ideation |
3.1% |
| Type 1 Diabetes Mellitus |
2.9% |
| Suicide Attempt |
2.8% |
| Urinary Tract Infection |
2.4% |
| Withdrawal Syndrome |
2.2% |
| Somnolence |
2.0% |
| Drug Ineffective |
1.8% |
| Obesity |
1.8% |
| Psychotic Disorder |
1.7% |
| Vision Blurred |
1.7% |
| Death |
1.7% |
| White Blood Cell Count Decreased |
1.7% |
|
| Interacting |
| Product Used For Unknown Indication |
28.7% |
| Schizophrenia |
19.6% |
| Psychotic Disorder |
11.0% |
| Depression |
8.6% |
| Drug Use For Unknown Indication |
7.4% |
| Bipolar Disorder |
4.5% |
| Anxiety |
2.7% |
| Hyperthyroidism |
2.1% |
| Schizophrenia, Paranoid Type |
2.1% |
| Constipation |
1.7% |
| Schizoaffective Disorder |
1.5% |
| Hepatitis C |
1.4% |
| Mania |
1.4% |
| Sleep Disorder |
1.4% |
| Borderline Personality Disorder |
1.2% |
| Mental Disorder |
1.2% |
| Hypertension |
1.0% |
| Dysthymic Disorder |
0.9% |
| Head Injury |
0.9% |
| Huntington's Chorea |
0.9% |
|
| Weight Increased |
19.7% |
| Tremor |
14.1% |
| Drug Interaction |
7.7% |
| Neuroleptic Malignant Syndrome |
7.0% |
| Schizophrenia |
7.0% |
| Weight Decreased |
4.2% |
| Mental Status Changes |
3.5% |
| Overdose |
3.5% |
| Suicide Attempt |
3.5% |
| Thinking Abnormal |
3.5% |
| Akathisia |
2.8% |
| Metabolic Syndrome |
2.8% |
| Respiratory Depression |
2.8% |
| Restlessness |
2.8% |
| Supraventricular Extrasystoles |
2.8% |
| Total Cholesterol/hdl Ratio Increased |
2.8% |
| Unresponsive To Stimuli |
2.8% |
| Priapism |
2.1% |
| Somnolence |
2.1% |
| Speech Disorder |
2.1% |
|
